लोड हो रहा है...

Successful response to first-line treatment with osimertinib for choroidal metastasis from EGFR-mutated non-small-cell lung cancer

Purpose: Describe the use of osimertinib, a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, as the first-line treatment in a patient with choroidal and central nervous system metastases from EGFR-mutated non-small cell lung cancer. Observations: A 68-year-old man...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Matthew G. Field, H. Culver Boldt, Taher Abu Hejleh, Elaine M. Binkley
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Elsevier 2022-06-01
श्रृंखला:American Journal of Ophthalmology Case Reports
विषय:
ऑनलाइन पहुंच:http://www.sciencedirect.com/science/article/pii/S2451993622002055
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!